全文获取类型
收费全文 | 65794篇 |
免费 | 3475篇 |
国内免费 | 70篇 |
专业分类
耳鼻咽喉 | 956篇 |
儿科学 | 2034篇 |
妇产科学 | 1450篇 |
基础医学 | 9897篇 |
口腔科学 | 2342篇 |
临床医学 | 6025篇 |
内科学 | 11908篇 |
皮肤病学 | 1613篇 |
神经病学 | 6984篇 |
特种医学 | 3165篇 |
外国民族医学 | 22篇 |
外科学 | 9107篇 |
综合类 | 231篇 |
一般理论 | 32篇 |
预防医学 | 4222篇 |
眼科学 | 1284篇 |
药学 | 4471篇 |
中国医学 | 104篇 |
肿瘤学 | 3492篇 |
出版年
2023年 | 345篇 |
2022年 | 281篇 |
2021年 | 588篇 |
2020年 | 630篇 |
2019年 | 681篇 |
2018年 | 1393篇 |
2017年 | 1192篇 |
2016年 | 1529篇 |
2015年 | 1285篇 |
2014年 | 1487篇 |
2013年 | 2668篇 |
2012年 | 3378篇 |
2011年 | 3817篇 |
2010年 | 2063篇 |
2009年 | 1380篇 |
2008年 | 3759篇 |
2007年 | 3936篇 |
2006年 | 3721篇 |
2005年 | 3621篇 |
2004年 | 3480篇 |
2003年 | 3502篇 |
2002年 | 3451篇 |
2001年 | 2794篇 |
2000年 | 3523篇 |
1999年 | 1980篇 |
1998年 | 698篇 |
1997年 | 598篇 |
1996年 | 467篇 |
1995年 | 365篇 |
1994年 | 396篇 |
1993年 | 356篇 |
1992年 | 421篇 |
1991年 | 377篇 |
1990年 | 356篇 |
1989年 | 408篇 |
1988年 | 355篇 |
1987年 | 321篇 |
1986年 | 319篇 |
1985年 | 372篇 |
1984年 | 400篇 |
1983年 | 331篇 |
1982年 | 313篇 |
1981年 | 263篇 |
1980年 | 249篇 |
1979年 | 315篇 |
1978年 | 230篇 |
1977年 | 245篇 |
1976年 | 236篇 |
1975年 | 244篇 |
1973年 | 219篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
Dorit Gräbsch 《MedR Medizinrecht》2006,24(1):VI-VIII
Ohne Zusammenfassung 相似文献
3.
S Balzer D T Schneider M B Bernbeck M J?ger O Mils J Schaper R Willers R Krauspe U G?bel R Wessalowski 《International journal of hyperthermia》2006,22(6):451-461
PURPOSE: In children with locally advanced or recurrent malignant tumours, prognosis can be improved by regional deep hyperthermia (RHT) in combination with platin-based chemotherapy. However, because of the increasing number of patients that achieve long-time remission with this therapy, it is necessary to evaluate long-term sequelae of thermochemotherapy. During the years 1993-2004 one has observed avascular osteonecrosis (AON) of the femoral head after RHT in seven children with pelvic germ cell tumours or rhabdomyosarcomas. METHODS: Although AON may develop in patients with malignancies treated with chemo- or radiotherapy alone, RHT might nevertheless contribute to the occurrence of AON. In order to determine potential risk factors for AON after RHT, this study analysed the relationship of AON to the patient's age, medical history and treatment parameters such as thermal dose equivalent and power output. RESULTS AND CONCLUSIONS: In the present study AON was associated with young age as well as intensity of hyperthermia indicated by high power levels that exceed 20 W per kg body weight and/or application of eight or more heat sessions as well as additional radiotherapy. Based on this observation, it was assumed that an optimized three dimensional thermal field modelling may be helpful to avoid hazardous temperatures in the femoral heads during RHT treatment and to reduce AON of the femoral heads. 相似文献
4.
Dorit Gräbsch 《MedR Medizinrecht》2006,24(4):VI-VIII
Ohne Zusammenfassung 相似文献
5.
Results of Transplanting Developing Third Molars as Part of Orthodontic Space Management 总被引:2,自引:0,他引:2
Oskar Bauss Reza Sadat-Khonsari Werner Engelke Bärbel Kahl-Nieke 《Journal of orofacial orthopedics》2002,63(6):483-492
PATIENTS AND METHOD: The aim of the present study was to contribute to a more accurate indication and better integration of developing third molar transplantation into orthodontic space management, using the results gleaned from the authors' own pool of patients. For this purpose, a clinical and radiographic examination of 61 transplanted developing molars in 57 patients was carried out after an average of 3.3 years. RESULTS: The overall success rate was 85%. Failure was due in 10% of cases to impaired periodontal healing (inflammatory root resorption, ankylosis, or increased pocket probing depths) and in 5% of cases to insufficient or arrested postoperative root development accompanied by increased transplant mobility. The incidence of postoperative cessation of further root development was significantly higher (p = 0.011) in transplants at early developmental stages, which also had a negative impact on the final root length, the crown-root ratio and the mobility values of these transplants. CONCLUSIONS: The transplantation of developing third molars should be given stronger consideration in treatment plans for orthodontic space management although it represents a real alternative to orthodontic space closure only in exceptional cases. However, unlike implantological or prosthodontic treatment, it offers an opportunity to replace a missing or non-retainable tooth with a patient's own vital and fully functional tooth, provided the appropriate transplant is selected. 相似文献
6.
7.
Peter Chiba Barbara Tell Walter Jger Elisabeth Richter Manuela Hitzlera Gerhard Ecker 《Archiv der Pharmazie》1997,330(11):343-347
A series of 5-hydroxy and 5-benzyloxy analogs of the antiarrhythmic and multidrug resistance (MDR) modulating drug propafenone was synthesized and the MDR-modulating activity of the compounds was evaluated using a daunomycin efflux assay system. The key step of the synthesis is the selective reduction of the double bond in 1 without cleavage of the benzyl group thus leading to the phenol 3 . Alkylation with epichlorohydrine followed by nucleophilic epoxide ring opening gave the benzylated target compounds 5a–d . Subsequent cleavage of the benzyl group gave the 5-hydroxy analogs 6a–d . Structure activity relationship studies showed, that the 5-hydroxy derivates 6a–d fit the log P/log potency correlation line previously established for a series of propafenone analogs. In contrast, all four 5-benzyloxy analogs 5a–d showed almost identical EC50 values, independent of their log P value. 相似文献
8.
9.
10.
(E)-5-(2-Bromovinyl)-2'-deoxyuridine (1; BrVUdR) inhibits the replication of herpes simplex virus type 1 (HSV-1) and of varicella-zoster virus (VZV) in vitro at concentrations of 0.01 to 0.23 mumol/l, whereas herpes simplex virus type 2 (HSV-2) is influenced only at 5.5 to 27 mumol/l. In comparison to some classical and newly developed antiherpetics, i. e. 5-iodo-2'-desoxyuridine (2; idoxuridine, IDU), 9-beta-D-arabinofuranosyladenine (4; vidarabine Ara-A), 9-(2-hydroxyethoxymethyl) guanine (5; acyclovir, ACV) and 2'-fluoro-5-iodo-1-beta-D-aracytosine (6;FIAC) the following order of decreasing activity was found:1 greater than 6 greater than 5 greater than 2 greater than 4 (against HSV-1) and 6 greater than 2 greater than 5 greater than 1 greater than 4 (against HSV-2). The high selectivity of the antiviral effect of BrVUdR towards HSV-1 and TZV is based on the fact, that proliferation of different mammalian cell lines is inhibited by 50% only at concentrations as high as 90 to 170 mumol/l, resulting in a therapeutical index of 1000 to 10,000. Successful treatment of an HSV-1 encephalitis in mice as well as an HSV-1 keratitis of rabbits confirmed the efficiency of 1 in experimental animal infections. No toxic side effects in both local and systemic applications were observed. Promising data from cell culture and animal experiments recommend 1 as a potential candidate for the local and systemic treatment of HSV-1 and VZV infections in man. 相似文献